Common Contracts
18 similar Underwriting Agreement contracts by Aphria Inc., Valens Company, Inc., Field Trip Health Ltd., Cybin Inc.
UNDERWRITING AGREEMENTUnderwriting Agreement • May 14th, 2022 • British Columbia
Canaccord Genuity Corp. ("Canaccord") and Beacon Securities Limited ("Beacon") as co-lead underwriters and joint bookrunners, Echelon Wealth Partners Inc. and Paradigm Capital Inc. (collectively, the "Underwriters" and each individually, an "Underwriter") hereby severally, and not jointly, nor jointly and severally, in their respective percentages set out in Section 19 below, offer to purchase from CloudMD Software & Services Inc. (the "Corporation"), and the Corporation hereby agrees to issue and sell to the Underwriters, 18,572,000 units of the Corporation (the "Units"), on an underwritten basis, at the purchase price of $0.70 per Unit (the "Offering Price"), for aggregate gross proceeds of $13,000,400.
UNDERWRITING AGREEMENTUnderwriting Agreement • March 31st, 2022 • Valens Company, Inc. • Medicinal chemicals & botanical products • Ontario
UNDERWRITING AGREEMENTUnderwriting Agreement • November 17th, 2021 • Valens Company, Inc. • Ontario
UNDERWRITING AGREEMENTUnderwriting Agreement • November 17th, 2021 • Valens Company, Inc. • Ontario
UNDERWRITING AGREEMENTUnderwriting Agreement • July 26th, 2021 • Cybin Inc. • Ontario
The Warrants shall be duly and validly created and issued pursuant to, and governed by, a warrant indenture (the "Warrant Indenture") in a form acceptable to the Lead Underwriter (acting reasonably) to be dated as of the Closing Date between the Corporation and the Transfer Agent (as defined below), in its capacity as warrant agent. The description of the Warrants herein is a summary only and is subject to the specific attributes and detailed provisions of the Warrants to be set forth in the Warrant Indenture. In case of any inconsistency between the description of the Warrants in this Agreement (as defined below) and the terms of the Warrants set forth in the Warrant Indenture, the provisions of the Warrant Indenture will govern.
UNDERWRITING AGREEMENTUnderwriting Agreement • July 19th, 2021 • Field Trip Health Ltd. • Ontario
UNDERWRITING AGREEMENTUnderwriting Agreement • July 19th, 2021 • Field Trip Health Ltd. • Ontario
UNDERWRITING AGREEMENTUnderwriting Agreement • November 13th, 2020 • British Columbia
Canaccord Genuity Corp. as lead underwriter and sole bookrunner (the “Lead Underwriter”), together with ATB Capital Markets Inc. and Leede Jones Gable Inc. (collectively, the “Underwriters” and each individually, an “Underwriter”) hereby severally, and not jointly, nor jointly and severally, in their respective percentages set out in Section 18 below, offer to purchase from Khiron Life Sciences Corp. (the “Corporation”) and the Corporation hereby agrees to issue and sell to the Underwriters, 28,000,000 units of the Corporation (each, a “Unit”), on an underwritten basis, at the purchase price of $0.45 per Unit (the “Offering Price”), for aggregate gross proceeds of $12,600,000. Each Unit shall be comprised of one common share of the Corporation (each, a “Common Share” and as a constituent of the Unit, a “Unit Share”) and one Common Share purchase warrant of the Corporation (each, a “Warrant”). Each Warrant shall entitle the holder thereof to acquire, subject to adjustment in certain cir
UNDERWRITING AGREEMENTUnderwriting Agreement • September 8th, 2020 • British Columbia
Canaccord Genuity Corp. ("Canaccord") and Beacon Securities Limited ("Beacon") as co-lead underwriters and joint bookrunners, Echelon Wealth Partners Inc. and Mackie Research Capital Corporation (collectively, the "Underwriters" and each individually, an "Underwriter") hereby severally, and not jointly, nor jointly and severally, in their respective percentages set out in Section 19 below, offer to purchase from CloudMD Software & Services Inc. (the "Corporation"), and the Corporation hereby agrees to issue and sell to the Underwriters, 13,100,000 common shares of the Corporation (the "Offered Shares"), on an underwritten basis, at the purchase price of $1.38 per Share (the "Offering Price"), for aggregate gross proceeds of $18,078,000.
UNDERWRITING AGREEMENTUnderwriting Agreement • August 7th, 2020 • Ontario
Clarus Securities Inc. (“Clarus”), as lead underwriter, and AltaCorp Capital Inc., (together, the “Underwriters” and each individually, an “Underwriter”) hereby severally, and not jointly, nor jointly and severally, in their respective percentages set out in Section 18 below, offer to purchase from Liberty Health Sciences Inc. (the “Corporation”) and the Corporation hereby agrees to issue and sell to the Underwriters, 9,523,810 units (the “Initial Units”) at a price of $2.10 per Initial Unit (the “Offering Price”) for aggregate gross proceeds of
UNDERWRITING AGREEMENTUnderwriting Agreement • June 3rd, 2020 • Ontario
UNDERWRITING AGREEMENTUnderwriting Agreement • May 29th, 2020 • British Columbia
Canaccord Genuity Corp. ("Canaccord") and Beacon Securities Limited ("Beacon") as co-lead underwriters and joint bookrunners, Echelon Wealth Partners Inc. and Paradigm Capital Inc. (collectively, the "Underwriters" and each individually, an "Underwriter") hereby severally, and not jointly, nor jointly and severally, in their respective percentages set out in Section 19 below, offer to purchase from CloudMD Software & Services Inc. (the "Corporation"), and the Corporation hereby agrees to issue and sell to the Underwriters, 18,572,000 units of the Corporation (the "Units"), on an underwritten basis, at the purchase price of $0.70 per Unit (the "Offering Price"), for aggregate gross proceeds of $13,000,400.
UNDERWRITING AGREEMENTUnderwriting Agreement • October 18th, 2018 • Aphria Inc. • Ontario
UNDERWRITING AGREEMENTUnderwriting Agreement • October 18th, 2018 • Aphria Inc. • Ontario
UNDERWRITING AGREEMENTUnderwriting Agreement • October 18th, 2018 • Aphria Inc. • Ontario
UNDERWRITING AGREEMENTUnderwriting Agreement • September 21st, 2018 • Ontario
The Warrants shall be duly and validly created and issued pursuant to, and governed by, a warrant indenture (the “Warrant Indenture”) in a form acceptable to the Co-Lead Underwriters to be dated as of the Closing Date between the Corporation and the Transfer Agent (as defined below), in its capacity as warrant agent. The description of the Warrants herein is a summary only and is subject to the specific attributes and detailed provisions of the Warrants to be set forth in the Warrant Indenture. In case of any inconsistency between the description of the Warrants in this Agreement and the terms of the Warrants set forth in the Warrant Indenture, the provisions of the Warrant Indenture will govern.
UNDERWRITING AGREEMENTUnderwriting Agreement • October 17th, 2017 • British Columbia
Canaccord Genuity Corp. (“Canaccord”), as lead underwriter, and GMP Securities L.P. (collectively, the “Underwriters” and each individually, an “Underwriter”) hereby severally, and not jointly, nor jointly and severally, in their respective percentages set out in Section 19 below, offer to purchase from Patriot One Technologies Inc. (the “Corporation”) and the Corporation hereby agrees to issue and sell to the Underwriters, 8,350,000 Units of the Corporation (the “Initial Units”), on an underwritten basis, at the purchase price of $1.20 per Initial Unit (the “Offering Price”), for aggregate gross proceeds of $10,020,000.
UNDERWRITING AGREEMENTUnderwriting Agreement • June 13th, 2014 • Ontario
Dundee Securities Ltd. (the “Lead Underwriter”), together with Edgecrest Capital Corporation, Haywood Securities Inc. and Mackie Research Capital Corporation (collectively, the “Underwriters”, and each individually, an “Underwriter”) hereby severally, and not jointly, nor jointly and severally, in their respective percentages set out in Section 18 below, offer to purchase from Wellgreen Platinum Ltd. (the “Corporation”), and the Corporation hereby agrees to issue and sell to the Underwriters, 9,231,000 units of the Company (“Units”), on a “bought deal” underwritten basis, at a price per Unit of $0.65 per Unit (the “Offering Price”) for aggregate gross proceeds of $6,000,150. Each Unit will consist of one Common Share (as defined below) in the capital of the Company (each, a “Unit Share”) and one common share purchase warrant (a “Warrant”). Each Warrant will entitle the holder to purchase one common share in the capital of the Corporation (each a “Warrant Share”) at an exercise price of
